Clinical safety of a 1-h infusion of cisplatin approach in a broad cancer population
Journal of Oncology Pharmacy Practice
Published online on May 13, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionCisplatin has ubiquitous use throughout many cancer types and is incorporated in various regimens. Nephrotoxicity is a well-known side effect of cisplatin, occurring in up to one third of patients. Early clinical data showed elevated peak ...
IntroductionCisplatin has ubiquitous use throughout many cancer types and is incorporated in various regimens. Nephrotoxicity is a well-known side effect of cisplatin, occurring in up to one third of patients. Early clinical data showed elevated peak ...